Filing Details
KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) filed its annual report (Form 10-K) with the Securities and Exchange Commission on July 14, 2026.
The Healthcare company's annual report covers fiscal year 2026.
10k filedNASDAQ:KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Files Annual Report with SEC
Filing Details KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) filed its annual report (Form 10-K) with the Securities and Exchange Commission on July 14, 2026. The Healthcare…
Market Context
KESTRA MEDICAL TECHNOLOGIES, LTD.'s stock currently trades at $24.18 with a market capitalization of $1.3B.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For KESTRA MEDICAL TECHNOLOGIES, LTD. investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for KESTRA MEDICAL TECHNOLOGIES, LTD. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View KMTS Stock Page
Frequently Asked Questions
Where can I read KMTS's SEC filings?
Browse all filings on our KMTS SEC filings page.
What types of SEC filings does KESTRA MEDICAL TECHNOLOGIES, LTD. file?
Public companies like KESTRA MEDICAL TECHNOLOGIES, LTD. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.